Evidence Around BCL2 Inhibitors for Patients with t(11;14) Translocation in MM
August 18th 2022Drs Shaji Kumar and Jonathan Kaufman review the BELLINI trial, as well as provide an overview of other investigational studies of BCL2 inhibitors for the treatment of patients with t(11;14) translocation with relapsed refractory multiple myeloma.
Read More